For the Inventor, By the Inventor

Enter assignee name

Mountain View, CA, United States of America

Scios Nova, Inc.

USPTO Granted Patents = 40

% Expired Patents = 2.5

CIPO Patents = 1

Forward Citations = 857

Loading Chart...

Loading Chart...

51 inventors (with patents filed for the assignee):

Barbara Cordell (6 out of 26 patents)

Donald J Kyle (6 out of 16 patents)

Robert M Scarborough (4 out of 153 patents)

4. Judith A Abraham (4 out of 15 patents)

5. David D Lesikar (4 out of 9 patents)

6. James W Schilling, Jr (4 out of 10 patents)

7. Bradley J Benson (4 out of 14 patents)

8. John C Fiddes (3 out of 9 patents)

9. Douglas I Buckley (3 out of 9 patents)

10. Lorin K Johnson (3 out of 19 patents)

11. John P Longenecker (3 out of 4 patents)

12. S Joseph Tarnowski (3 out of 4 patents)

13. Kate B Silverness (3 out of 4 patents)

14. Richard Eric Mewshaw (2 out of 64 patents)

15. Babu J Mavunkel (2 out of 22 patents)

Core Competencies:

Protease Inhibitor Peptides

Bradykinin Antagonists

Anti-Inflammatory Agents

Recombinant Proteins

Fibroblast Growth Factors

Atrial Natriuretic Peptides

Alzheimer's Disease

Phospholipase Inhibitors

Surfactant Proteins

Transgenic Mice

Amyloid Depositions

DNA Encoding

40 patents: Sort by Forward Citations

1. 6906033 - Protease inhibitor peptides (2005-06-14),

2. 6376648 - Protease inhibitor peptides (2002-04-23),

3. 5811393 - Heparin binding mitogen with homology to epidermal growth factor (EGF) (1998-09-22),

4. 5646254 - Antibodies for human phospholipase inhibitory protein (hPIP) (1997-07-08),

5. 5552383 - Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids (1996-09-03),

6. 5543496 - Cyclic bradykinin antagonist peptides (1996-08-06),

7. 5541286 - Bradykinin antagonist pseudopeptide derivatives of olefinic (1996-07-30),

8. 5530157 - Anti-inflammatory benzoic acid derivatives (1996-06-25),

9. 5521158 - Pseudopeptide bradykinin receptor antagonists (1996-05-28),

10. 5519043 - Fluorenyl derivatives (1996-05-21),

11. 5514566 - Methods of producing recombinant fibroblast growth factors (1996-05-07),

12. 5512455 - Atrial natriuretic peptide receptor protein (1996-04-30),

13. 5472973 - Fluorenyl derivatives as anti-inflammatory agents (1995-12-05),

14. 5449662 - Atrial natriuretic peptide clearance inhibitors which resist degradation (1995-09-12),

15. 5446020 - Method of treating diabetes with tissue-selective insulin analogs (1995-08-29),

Company Overview

Scios Nova, Inc., based in Mountain View, CA, specializes in the development of innovative therapeutic solutions targeting complex diseases. The company focuses on advanced peptide technologies, including protease inhibitor peptides and bradykinin antagonist peptides, to address conditions such as Alzheimer's disease and inflammation. Additionally, Scios Nova is engaged in research involving recombinant fibroblast growth factors and lung surfactant proteins, leveraging transgenic mouse models to enhance its understanding of these critical biological processes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

40 Patents

#83 in Mountain View, CA

#2,041 in California

#8,635 in US

#17,087 in the World

Mountain View, CA, United States of America

Scios Nova, Inc.

Forward Citations = 857

51 inventors:

Barbara Cordell (6 out of 26 patents)

Donald J Kyle (6 out of 16 patents)

Robert M Scarborough (4 out of 153 patents)

4. Judith A Abraham (4 out of 15 patents)

5. David D Lesikar (4 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Scios Nova, Inc.. Retrieved from https://idiyas.com/company/scios-nova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…